Your session is about to expire
← Back to Search
Resilience Training and Problem-Solving Therapy for Postpartum Depression in Home Visited Mothers
N/A
Waitlist Available
Led By Fallon Cluxton-Keller, Ph.D.
Research Sponsored by Dartmouth-Hitchcock Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline emotion regulation questionnaire-cognitive reappraisal scale score at 6 months
Awards & highlights
Study Summary
This trial is testing a new family therapy intervention that uses technology to help depressed mothers.
Eligible Conditions
- Postpartum Depression
- Family Conflict
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline multidimensional scale of perceived social support-family subscale score at 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline multidimensional scale of perceived social support-family subscale score at 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Beck Depression Inventory-Second Edition
Emotion Regulation Questionnaire-Cognitive Reappraisal scale (Adult version, and Children and Adolescents version)
Multidimensional Scale of Perceived Social Support - Family subscale
+1 moreSecondary outcome measures
Maternal school enrollment/job attainment
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Resilience Enhancement Skills TrainingExperimental Treatment1 Intervention
video-based family therapy
Group II: Standard of careActive Control1 Intervention
video-based individual therapy
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resilience Enhancement Skills Training
2021
N/A
~170
Find a Location
Who is running the clinical trial?
Dartmouth-Hitchcock Medical CenterLead Sponsor
528 Previous Clinical Trials
2,541,210 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,798 Previous Clinical Trials
2,660,752 Total Patients Enrolled
24 Trials studying Postpartum Depression
7,977 Patients Enrolled for Postpartum Depression
Fallon Cluxton-Keller, Ph.D.Principal InvestigatorDartmouth-Hitchcock Clinic
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- Your family is currently undergoing therapy together.You are a mother with symptoms of bipolar disorder.Mothers with moderate to severe depression symptoms, as identified by the Beck Depression Inventory-Second Edition score of at least 20.The mother or any of her family members have experienced symptoms of psychosis.The mother or a family member has expressed thoughts of wanting to harm themselves.The adult mother and her adult family member have a score of at least 16 on the Perceived Hostility Survey, while the adolescent mother and her adolescent intimate partner have a score of at least 14 on the same survey.If you are a mother and have been taking an antidepressant for less than 2 months.Your household has a history of violence.
Research Study Groups:
This trial has the following groups:- Group 1: Resilience Enhancement Skills Training
- Group 2: Standard of care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger